West Nile Virus in Europe and Safety of Blood Transfusion

Transfusion Medicine and Hemotherapy

Volumn 43, Issue 3, 2016, Pages 158-167

  Pisani, Giulio ^a   Cristiano, Karen ^a   Pupella, Simonetta ^a   Liumbruno, Giancarlo Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

NAT; Proficiency panel; Transfusion risks; Virus transmission; West Nile virus

Indexed keywords

BLOOD TRANSFUSION; EUROPE; HUMAN; ORGAN TRANSPLANTATION; SAFETY; VIRUS TRANSMISSION; WEST NILE VIRUS;

EID: 84973483427     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000446219     Document Type: Review

References (64)

1. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E: West Nile virus: biology, transmission, and human infection. Clin Microbiol Rev 2012; 25: 635-648.
2. Pauli G, Bauerfeind U, Blumel J, Burger R, Drosten C, Groner A, Gurtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H: West Nile virus. Transfus Med Hemother 2013; 40: 265-284.
3. Rizzoli A, Jimenez-Clavero MA, Barzon L, Cordioli P, Figuerola J, Koraka P, Martina B, Moreno A, Nowotny N, Pardigon N, Sanders N, Ulbert S, Tenorio A: The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill 2015; 20:pii: 21135.
4. Bondre VP, Jadi RS, Mishra AC, Yergolkar PN, Arankalle VA: West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol 2007; 88: 875-884.
5. Blitvich BJ: Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev 2008; 9: 71-86.
6. Bakonyi T, Ivanics E, Erdely K, Ursu K, Ferenczi E, Weissenbock H, Nowotny N: Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis 2006; 12: 618-623.
7. Wodak E, Richter S, Bago Z, Revilla-Fernandez S, Weissenbock H, Nowotny N, Winter P: Detection and molecular analysis of West Nile virus infections in birds of prey in the eastern part of Austria in 2008 and 2009. Vet Microbiol 2011; 149: 358-366.
8. Papa A, Bakonyi T, Xanthopoulou K, Vasquez A, Tenorio A, Nowotny N: Genetic characterization of West Nile virus lineage 2 Greece, 2010. Emerg Infect Dis 2011; 17: 920-922.
9. Bagnarelli P, Marinelli K, Trotta D, Monachetti A, Tavio M, Del Gobbo R, Capobianchi MR, Menzo S, Nicoletti L, Magurano F, Varaldo PE: Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. Euro Surveill 2011; 16:pii: 20002.
10. Platonov AE, Karan LS, Shopenskaia TA, Fedorova MV, Koliasnikova NM, Rusakova NM, Shishkina LV, Arshba TE, Zhuravlev VI, Govorukhina MV, Valentseva AA, Shipulin GA: Genotyping of West Nile fever virus strains circulating in southern Russia as an epidemiological investigation method: principles and results (in Russian). Zh Mikrobiol Epidemiol Immunobiol 2011; 2: 29-37.
11. Sirbu A, Ceianu CS, Panculescu-Gatej RI, Vazquez A, Tenorio A, Rebreanu R, Niedrig M, Nicolescu G, Pistol A: Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Euro Surveill 2011; 16:pii:19762.
12. Kolodziejek J, Marinov M, Kiss BJ, Alexe V, Nowotny N: The complete sequence of a West Nile virus lineage 2 strain detected in a Hyalomma marginatum marginatum tick collected from a song thrush (Turdus philomelos) in eastern Romania in 2013 revealed closest genetic relationship to strain Volgograd 2007. PLoS One 2014; 9:e109905.
13. Fonseca DM, Keyghobadi N, Malcolm CA, Mehmet C, Schaffner F, Mogi M, Fleischer RC, Wilkerson RC: Emerging vectors in the Culex pipiens complex. Science 2004; 303: 1535-1538.
14. Anderson JF, Main AJ: Importance of vertical and horizontal transmission of West Nile virus by Culex pipiens in the Northeastern United States. J Infect Dis 2006; 194: 1577-1579.
15. Centers for Disease Control and Prevention (CDC): Intrauterine West Nile virus infection-New York, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1135-1136.
16. Centers for Disease Control and Prevention (CDC): Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 877-878.
17. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME; West Nile Virus Transmission Investigation Team: Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-1245.
18. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, Pham SM, Zaki S, Lanciotti RS, Lance-Parker SE, DiazGranados CA, Winquist AG, Perlino CA, Wiersma S, Hillyer KL, Goodman JL, Marfin AA, Chamberland ME, Petersen LR; West Nile Virus in Transplant Recipients Investigation Team: Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196-2203.
19. Sampathkumar P: West Nile virus: epidemiology, clinical presentation, diagnosis and prevention. Mayo Clin Proc 2003; 78: 1137-1144.
20. Sejvar JJ: The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007; 44: 1617-1624.
21. Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, Rathbone M, Drebot M, Neupane B, Fearon M, Mahony J: Prognosis after West Nile virus infection. Ann Intern Med 2008; 149: 232-241.
22. Niedrig M, Sonnenberg K, Steinhagen K, Paweska JT: Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralization. J Virol Methods 2007; 139: 103-105.
23. Sanchini A, Donoso-Mantke O, Papa A, Sambri V, Teichmann A, Niedrig M: Second international diagnostic accuracy study for the serological detection of West Nile virus infection. PLoS Negl Trop Dis 2013; 7:e2184.
24. European Commission: Commission implementing decision of August 8, 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 27.9.2012: L 262: 1-57.
25. Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP: Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol 2007; 14: 1226-1230.
26. Barzon L, Pacenti M, Franchin E, Pagni S, Martello T, Cattai M, Cusinato R, Palu G: Excretion of West Nile virus in urine during acute infection. J Infect Dis 2013; 208: 1086-1092.
27. Barzon L, Pacenti M, Franchin E, Squarzon L, Sinigaglia A, Ulbert S, Cusinato R, Palu G: Isolation of West Nile virus from urine samples of patients with acute infection. J Clin Microbiol 2014; 52: 3411-3413.
28. Seino KK, Long MT, Gibbs ET, Bowen RA, Beachboard SE, Humphrey PP, Dixon MA, Bourgeois MA: Comparative efficacies of three commercially available vaccines against West Nile virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Clin Vaccine Immunol 2007; 14: 1465-1471.
29. Anderson J, Rahal JJ: Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8: 107-108.
30. Diamond MS: Progress on the development of therapeutics against West Nile virus. Antiviral Res 2009; 83: 214-227.
31. Ben-Nathan D, Gershoni-Yahalom O, Samina I, Khinich Y, Nur I, Laub O, Gottreich A, Simanov M, Porgador A, Rager-Zisman B, Orr N: Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis 2009; 17: 9-18.
32. Smithburn KC, Hughes TP, Burke AW, Paul JH: A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940; 20: 471-492.
33. Murgue B, Zeller H, Duebel V: The ecology and epidemiology of West Nile virus in Africa, Europe and Asia; in Mackenzie JS, Barrett AD, Deubel V (eds): Japanese Encephalitis and West Nile Viruses. New York, Springer, 2002, pp 195-221.
34. Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, Savini G, Lelli R: Epidemiology of West Nile in Europe and in the Mediterranean Basin. Open Virol J 2010; 4: 29-37.
35. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ: Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286: 2333-2337.
36. Biggerstaff BJ, Petersen LR: Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019-1026.
37. Centers for Disease Control and Prevention (CDC): Update: West Nile virus screening of blood donations and transfusion-associated transmission-United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 281-284.
38. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research: Guidance for Industry: Assessing Donor Suitability and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection. 2005. www.fda.gov/BiologicsBloodVaccines/GuidanceCompliance RegulatoryInformation/Guidances/Blood/ucm074111. htm (last accessed April 21, 2016).
39. De Oliveira AM, Beecham BD, Montgomery SP, Lanciotti RS, Linnen JM, Giachetti C, Pietrelli LA, Stramer SL, Safranek TJ: West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 2004; 44: 1695-1699.
40. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA: West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 2006; 12: 395-402.
41. Tsai TF, Popovici F, Cernercu C, Campbell GL, Nedelcu NI: West Nile encephalitis epidemic in south-eastern Romania. Lancet 1998; 352: 767-771.
42. European Centre for Disease Prevention and Control: Review of the epidemiological situation of West Nile virus infection in the European Union. Update September 19, 2011. http://ecdc.europa.eu/en/publications/Publications/110920-TER-Rapid%20risk%20assessment-WNF.pdf (last accessed April 21, 2016)
43. Berger SA: West Nile Fever: Global Status, 2012. Los Angeles, Gideon e-books, 2012. Available at. www. gideononline.com/ebooks/disease/west-nile-fever-globalstatus
44. Commission Directive 2004/33/EC of March 22, 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. 30.03.2004: L91: 25-39.
45. Commission Directive 2002/98/EC of the European Parliament and of the Council of January 27, 2003. Setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. 08.02.2003: L33: 30-40.
46. Commission Decision 2007/875/EC amending Decision No 2119/98/EC of the European Parliament and of the Council and Decision 2000/96/EC as regards communicable diseases listed in those decisions. 28.12.2007: L344: 48-49.
47. Commission Decision 2008/426/EC amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision N° 2119/98/EC of the European Parliament and of the Council. 18.06.2008: L159: 46-90.
48. European Commission Decision 2009/312/EC. Amending Decision 2000/96/EC as regards dedicated surveillance networks for communicable diseases 03.04.2009: L91: 27-30.
49. Zeller HG, Schuffenecker I: :West Nile virus: an overview of its spread in Europe and the Mediterranean Basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004; 23: 147-156.
50. Paul-Ehrlich-Institut: Bekanntmachung uber die Zulassung von Arzneimitteln-Abwehr von Arzneimittelrisiken Stufe II-Anderung des Bescheides uber die Anordnung des Ausschlusses von Blutspendern zur Verhinderung einer moglichen Ubertragung des West-Nil-Virus durch nicht pathogen-inaktivierte Blutkomponenten. Bundesanzeiger 07.03.2014 B6.
51. Dreier J, Vollmer T, Hinse D, Heuser EJ, Pisani G, Knabbe C: Implementation of NAT Screening for West Nile virus and experience with seasonal testing in Germany. Transfus Med Hemother 2016; 43: 28-36.
52. Pai A, Kleinman S, Malhotra K, Lee-Haynes L, Pietrelli L, Saldanha J: Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay. Transfusion 2008; 48: 2184-2189.
53. Linnen JM, Deras ML, Cline J, Wu W, Broulik AS, Cory RE, Knight JL, Cass MM, Collins CS, Giachetti C: Performance evaluation of the Procleix West Nile virus assay on semi-automated and automated aystems. J Med Virol 2007; 79: 1422-1430.
54. Baylis SA, Chudy M, Nubling CM: Standardization of NAT for blood-borne pathogens. Transfus Med Hemother 2015; 42: 211-218.
55. Saldanha J, Shead S, Heath A, Drebot M; West Nile Virus Collaborative Study Group: Collaborative study to evaluate a working reagent for West Nile virus RNA detection by nucleic acid testing. Transfusion 2005; 45: 97-102.
56. Dodd RY, Foster GA and Stramer SL: Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012. Transfusion Med Rev 2015; 29: 153-161.
57. Pupella S, Pisani G, Cristiano K, Catalano L, Grazzini G: Update on West Nile virus in Italy. Blood Transfus 2014; 12: 626-627.
58. Commission Directive 2014/110/EU amending Directive 2004/33/EC as regards temporary deferral criteria for donors of allogeneic blood donations. Official Journal of the European Union. 17.12.2014: L 366: 81-82.
59. European Directive 2005/62/EC 'implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments'. Official Journal of the European Union. 30.09.2005: L256: 41-48.
60. Pisani G, Pupella S, Marino F, Gaggioli A, Sambri V, Rossini G, Wirz M, Grazzini G: Interlaboratory study to evaluate the performance of laboratories involved in West Nile virus RNA screening of blood and blood components by nucleic acid amplification testing in Italy. Blood Transfus 2011; 9: 425-429.
61. Pisani G, Pupella S, Cristiano K, Marino F, Simeoni M, Luciani F, Scuderi G, Sambri V, Rossini G, Gaibani P, Pierro A, Wirz M, Grazzini G: Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for WNV by NAT. Blood Transfus 2012; 0: 515-520.
62. Pupella S, Pisani G, Cristiano K, Catalano L, Grazzini G: West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety. Blood Transfus 2013; 11: 563-574.
63. Napoli C, Iannetti S, Rizzo C, Bella A, Di Sabatino D, Bruno R, Sauro F, Martini V, Santucci VU, Declich S, Calistri P: Vector borne infections in Italy: results of the integrated surveillance system for West Nile disease in 2013. Biomed Res Int 2015; 2015: 643439.
64. Bellini R, Calzolari M, Mattivi A, Tamba M, Angelini P, Bonilauri P, Albieri A, Cagarelli R, Carrieri M, Dottori M, Finarelli AC, Gaibani P, Landini MP, Natalini S, Pascarelli N, Rossini G, Velati C, Vocale C, Bedeschi E: The experience of West Nile virus integrated surveillance system in the Emilia-Romagna region: five years of implementation, Italy, 2009 to 2013. Euro Surveill 2014; 19:pii: 20953.